20409 Health Library | Health and Wellness | Wellmont Health System
  • Medications for Prostate Cancer—Hormonal Therapy

    The information provided here is meant to give you a general idea about each of the medicines listed below. Only the most general side effects are included, so ask your doctor if you need to take any special precautions. Use each of these medicines as recommended by your doctor, or according to the instructions provided. If you have further questions about usage or side effects, contact your doctor.
    The type of treatment you will have will depend on the stage of the cancer, the size of the tumor, your age, and overall condition. The main prescription drug therapies used to treat prostate cancer are hormonal therapies.

    Hormonal Therapy

    Prostate cells need male hormones, called androgens, to grow and work properly. The aim of hormonal therapy is to reduce the amount of male hormones in your body so that prostate cells are not stimulated to grow. The most effective hormonal therapy is to undergo surgery to remove the testes (called orchiectomy). This is effective surgery, but it is irreversible. Often hormonal therapies are combined to achieve greater effects.
    Different types of hormonal therapies include:
    Luteinizing Hormone-releasing Hormone (LHRH) Analogs
    Common names include:
    • Leuprolide (Lupron)
    • Goserelin (Zoladex)
    These medicines decrease the production of the male hormone, testosterone, from your testicles. These medicines are given by injection into a muscle every few months.
    Possible side effects include:
    • Impotence
    • Hot flashes
    • Loss of sexual desire
    • Osteoporosis
    • Fatigue
    • Increased risk of heart disease and diabetes
    Anti-androgens
    Common names include:
    • Flutamide (Eulexin)
    • Bicalutamide (Casodex)
    • Nilutamide (Nilandron)
    Anti-androgens prevent your body from using androgens. Possible side effects include:
    • Nausea and vomiting
    • Diarrhea
    • Breast growth or tenderness
    • Change in sexual ability or desire
    Androgen Suppressants
    Common name: ketoconazole (Nizoral)
    Ketoconazole blocks the production of androgens. It is considered a second-line hormonal treatment. It may be used when other medicines are not working.
    Possible side effects include:
    • Nausea and vomiting
    • Liver problems
    • Itchy skin

    Newer Hormonal Therapies

    Abiraterone
    Common name: abiraterone (Zytiga)
    Abiraterone works by blocking an enzyme that is needed to make testosterone. The drug affects the ability of the testes and body tissue from making this male hormone.
    Possible side effects include:
    Enzalutamide (Xtandi)
    Common name: enzalutamide (Xtandi)
    This medicine has been approved by the Food and Drug Administration (FDA) for men that have late-stage prostate cancer that has not responded to other treatments. Enzalutamide, a type of anti-antigen, prevents your body from using androgens.
    Possible side effects include:
    • Weakness
    • Back pain
    • Diarrhea
    • Joint pain

    Special Considerations

    If you are taking medicines, follow these general guidelines:
    • Take your medicine as directed. Do not change the amount or the schedule.
    • Do not stop taking them without talking to your doctor.
    • Do not share them.
    • Know what the results and side effects. Report them to your doctor.
    • Some drugs can be dangerous when mixed. Talk to a doctor or pharmacist if you are taking more than one drug. This includes over-the-counter medicine and herb or dietary supplements.
    • Plan ahead for refills so you don’t run out.

    References

    Abiraterone for prostate cancer. Cancer Research UK website. Available at: http://cancerhelp.cancerresearchuk.org/about-cancer/cancer-questions/abiraterone-for-prostate-cancer. Accessed September 20, 2012.

    Abiraterone (Zytiga). Cancer Research UK website. Available at: http://cancerhelp.cancerresearchuk.org/about-cancer/treatment/cancer-drugs/abiraterone#common. Accessed September 20, 2012.

    Angiogenesis inhibitors. National Cancer Institute website. Available at: http://www.cancer.gov/cancertopics/factsheet/Therapy/angiogenesis-inhibitors. Accessed September 19, 2012.

    Detailed guide: prostate cancer. American Cancer Society website. Available at: http://www.cancer.org/ . Accessed October 9, 2008.

    Evolution of cancer treatments: targeted therapy. American Cancer Society website. Available at: http://www.cancer.org/Cancer/CancerBasics/TheHistoryofCancer/the-history-of-cancer-cancer-treatment-targeted-therapy. Updated June 8, 2012. Accessed September 19, 2012.

    Hormone (androgen deprivation) therapy for prostate cancer. American Cancer Society website. Available at: http://www.cancer.org/Cancer/ProstateCancer/DetailedGuide/prostate-cancer-treating-hormone-therapy. Updated September 4, 1012. Accessed September 19, 2012.

    Hormone therapy for prostate cancer. Mayo Clinic website. Available at: http://www.mayoclinic.com/health/hormone-therapy-for-prostate-cancer/MY01633. Updated August 10, 2012. Accessed September 19, 2012.

    Prostate cancer. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated August 20, 2012. Accessed September 19, 2012.

    Prostate cancer. National Cancer Institute website. Available at: http://www.cancer.gov/cancertopics/types/prostate . Accessed October 9, 2008.

    Study: new drug enzalutamide extends life in advanced prostate cancer. American Cancer Society website. Available at: http://www.cancer.org/Cancer/news/study-new-drug-enzalutamide-extends-life-in-advanced-prostate-cancer. Accessed September 20, 2012.

    Targeted therapy for prostate cancer. Texas Oncology website. Available at: http://www.texasoncology.com/types-of-cancer/prostate-cancer/targeted-therapy-for-prostate-cancer/. Accessed July 31, 2012.

    Xtandi (Enzalutamide) approved for late stage prostate cancer, FDA. Medical News Today website. Available at: http://www.medicalnewstoday.com/articles/249785.php. Accessed September 19, 2012.

    2/12/2010 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Smith DP, King MT, Egger S, et al. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ. 2009;339:b4817.

    10/25/2010 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed/what.php: US Food and Drug Administration. Include warnings on risk for class of prostate cancer drugs US Food and Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm230334.htm . Published October 20, 2010. Accessed October 25, 2010.

    Revision Information

  • Join WellZones today.

    Make a Change For LifeLearn more

    Wellmont LiveWell is creating a new tradition of wellness in the mountains by providing individuals with tools and encouragement to live healthier lifestyles.

  • HeartSHAPE Spotlight

    At risk for a heart attack? Learn more

    Fight heart disease early and prevent heart attacks with HeartSHAPE® - a painless, non-invasive test that takes pictures of your heart to scan for early-stage coronary disease.

  • Calories and Energy Needs

    Calorie NeedsLearn more

    How many calories do you need to eat each day to maintain your weight and fuel your physical activity? Enter a few of your stats into this calculator to find out.

  • Ideal Body Weight

    Ideal Body WeightLearn more

    Using body mass index as a reference, this calculator determines your ideal body weight range. All you need to do is enter your height.

  • Body Mass Index

    Body Mass IndexLearn more

    This tool considers your height and weight to assess your weight status.


  • Can we help answer your questions?

    Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.